Clincosm LogoSign in Get a demo

plasmodium falciparum infection

Showing 1 - 20 of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Plasmodium Falciparum Infection, Malaria Trial in Faladje, Kalifabougou, Torodo (L9LS (VRC-MALMAB0114-00-AB), Normal Saline)

Not yet recruiting
  • Plasmodium Falciparum Infection
  • Malaria
  • L9LS (VRC-MALMAB0114-00-AB)
  • Normal Saline
  • Faladje, Région De Koulikoro, Mali
  • +2 more
Apr 17, 2023

Plasmodium Falciparum Infection, Malaria Trial in Kalifabougou, Torodo (VRC-MALMAB0100-00-AB (CIS43LS), Normal saline)

Active, not recruiting
  • Plasmodium Falciparum Infection
  • Malaria
  • VRC-MALMAB0100-00-AB (CIS43LS)
  • Normal saline
  • Kalifabougou, Région De Koulikoro, Mali
  • +1 more
Sep 20, 2022

Plasmodium Falciparum Infection, Malaria Trial in Kisumu (L9LS, Normal Saline)

Recruiting
  • Plasmodium Falciparum Infection
  • Malaria
  • Kisumu, Kenya
    Kenya Medical Research Institute (KEMRI) Center for Global Healt
Sep 15, 2022

Plasmodium Falciparum Infection, Malaria Trial in Kalifabougou, Torodo (L9LS (VRC-MALMAB0114-00-AB), Normal saline)

Recruiting
  • Plasmodium Falciparum Infection
  • Malaria
  • L9LS (VRC-MALMAB0114-00-AB)
  • Normal saline
  • Kalifabougou, Région De Koulikoro, Mali
  • +1 more
Apr 7, 2022

Plasmodium Falciparum Infection Trial in Worldwide (Ferroquine SSR97193, Artefenomel, Placebo)

Terminated
Has Results
  • Plasmodium Falciparum Infection
  • Ferroquine SSR97193
  • +2 more
  • Cotonou, Benin
  • +11 more
Mar 15, 2022

Plasmodium Falciparum Infection Trial in Worldwide (Artefenomel (OZ439), Ferroquine (SSR97193))

Completed
Has Results
  • Plasmodium Falciparum Infection
  • Artefenomel (OZ439)
  • Ferroquine (SSR97193)
  • Cotonou, Benin
  • +6 more
Mar 10, 2022

Plasmodium Falciparum Infection Trial (Personal protection package)

Not yet recruiting
  • Plasmodium Falciparum Infection
  • Personal protection package
  • (no location specified)
Nov 2, 2021

Plasmodium Falciparum Infection Trial in Baltimore (NF54 P. falciparum malaria challenge)

Completed
  • Plasmodium Falciparum Infection
  • NF54 P. falciparum malaria challenge
  • Baltimore, Maryland
    University of Maryland School of Medicine - Center for Vaccine D
Jun 3, 2021

Plasmodium Falciparum Infection Trial in Seattle (drug, biological, other)

Completed
  • Plasmodium Falciparum Infection
  • Seattle, Washington
    Kaiser Permanente Washington Health Research Institute - Vaccine
Dec 24, 2019

Plasmodium Falciparum Infection Trial in Sikasso (drug, biological, other)

Completed
  • Plasmodium Falciparum Infection
  • Sikasso, Mali
    University of Bamako - Epidemiology of Parasitic Diseases - Mala
Nov 27, 2019

Plasmodium Falciparum Infection Trial in Seattle (Genetically-attenuated p52-/p36-/sap1- Plasmodium falciparum parasite (GAP3KO)

Completed
  • Plasmodium Falciparum Infection
  • Genetically-attenuated p52-/p36-/sap1- Plasmodium falciparum parasite (GAP3KO) strain
  • Malaria challenge
  • Seattle, Washington
    Kaiser Permanente Washington Health Research Institute - Vaccine
Sep 19, 2019

Plasmodium Falciparum Infection Trial in Ouagadougou (drug, biological, other)

Completed
  • Plasmodium Falciparum Infection
  • Ouagadougou, Kadiogo, Burkina Faso
    Centre National de Recherche et de Formation sur le Paludisme -
Jul 25, 2019

Plasmodium Falciparum Infection Trial in Baltimore (PfSPZ (7G8) Challenge, PfSPZ (NF54) Challenge)

Completed
  • Plasmodium Falciparum Infection
  • PfSPZ (7G8) Challenge
  • PfSPZ (NF54) Challenge
  • Baltimore, Maryland
    University of Maryland School of Medicine - Center for Vaccine D
Jan 24, 2019

Plasmodium Falciparum Infection Trial in Yangon (Artemether-lumefantrine 3 days, Artemether-lumefantrine 5 days)

Completed
  • Plasmodium Falciparum Infection
  • Artemether-lumefantrine 3 days
  • Artemether-lumefantrine 5 days
  • Yangon, Myanmar
    Medical Action Myanmar
Sep 18, 2018

Dihydroartemisinin-piperaquine for Treatment of Uncomplicated

Completed
  • Plasmodium Falciparum Infection
  • Plasmodium Vivax Infection
  • Timika, Indonesia
    Timika District Hospital
Jan 31, 2017

Plasmodium Falciparum Infection Trial in Stanford, Nashville (Placebo, Ad35.CS.01 Circumsporozoite Malaria Vaccine)

Completed
  • Plasmodium Falciparum Infection
  • Placebo
  • Ad35.CS.01 Circumsporozoite Malaria Vaccine
  • Stanford, California
  • +1 more
Sep 18, 2014

Plasmodium Falciparum Infection Trial in Blantyre (Atovaquone-proguanil, Artesunate, Azithromycin)

Completed
Has Results
  • Plasmodium Falciparum Infection
  • Blantyre, Malawi
    Blantyre Malaria Project - Ndirande Health Centre
Aug 7, 2014

Plasmodium Falciparum Infection Trial in Baltimore (NF54 P. falciparum isolate)

Completed
  • Plasmodium Falciparum Infection
  • NF54 P. falciparum isolate
  • Baltimore, Maryland
    University of Maryland School of Medicine - Center for Vaccine D
Aug 7, 2014

Plasmodium Vivax Infection, Plasmodium Vivax Clinical Episode, Plasmodium Falciparum Infection Trial in Maprik (Primaquine,

Completed
  • Plasmodium Vivax Infection
  • +3 more
  • Maprik, East Sepik Province, Papua New Guinea
    PNG Institute of Medical Research
May 19, 2014

Plasmodium Falciparum Infection Trial in Worldwide (Ferroquine (SSR97193), Placebo, artesunate)

Terminated
  • Plasmodium Falciparum Infection
  • Ferroquine (SSR97193)
  • +2 more
  • Cotonou, Benin
  • +9 more
Jun 27, 2011